<?xml version="1.0" encoding="UTF-8"?>
<p>One Nipah@20 session was devoted to the Nipah vaccine pipeline. At least 13 vaccine candidates have been confirmed to be under development in preclinical stages (
 <xref rid="B4" ref-type="bibr">4</xref>). Five of these active vaccine developers presented their latest preclinical data, with two speakers presenting on platform technologies that are being used for the development of COVID-19 vaccines.
</p>
